In addition to visceral fat reduction, retatrutide can enhance blood sugar management, decrease weight, and promote cardiovascular health
The obesity epidemic continues to affect millions of Americans, with approximately two-thirds of the population classified as overweight or obese.[1] Individuals who are overweight or have obesity are more likely to develop type 2 diabetes (T2D), though not everyone with excess weight develops the condition.[2] For non-diabetics seeking support with weight loss, semaglutide has gained significant attention
& Meijer, A
Patients taking ACE inhibitors, beta-blockers, or diuretics for cardiac management should discuss potential interactions with their prescribing physician
It is important to note that there is no official link suggesting Victoza directly produces sulfur compounds or uniquely targets sulfur metabolism
Compared to alternate T2D drugs, GLP-1RAs have a unique adverse effect profile that necessitates individualized prescribing based on tolerability and risk factors